Regeneron Pharmaceuticals, Inc.
Methods for treating or preventing asthma by administering an IL-4R antagonist
Last updated:
Abstract:
The invention provides methods for treating or preventing asthma and associated conditions in a patient. The methods featured in the invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody.
Status:
Grant
Type:
Utility
Filling date:
29 Oct 2018
Issue date:
15 Jun 2021